DD vs NRIX · P/E 127, rev $12.39B vs rev $54.5M
Dupont De Nemours Inc (DD) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
DD currently screens at market cap $19.61B and trailing P/E 127.4. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the DD and NRIX stock pages for the full models.
Not investment advice.